» Articles » PMID: 9722539

Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor. Phorbol Ester or [Ca2+]i Elevation Can Substitute for Receptor...

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Aug 29
PMID 9722539
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The activation of growth factor receptors and receptors coupled to heterotrimeric guanine nucleotide-binding proteins (G-proteins) can increase mitogen-activated protein (MAP) kinase activity in many cells. Previously, we demonstrated that the activation of G-protein-coupled P2Y2 receptors by extracellular ATP and UTP stimulated MAP (p42 ERK2) kinase by a mechanism that was dependent on the elevation of [Ca2+]i and the activation of related adhesion focal tyrosine kinase (RAFTK) (also called PYK2, CAKbeta, and CADTK) and protein kinase C (PKC). Here, we examine further the signaling cascade between the P2Y2 receptor and MAP kinase. MAP kinase was transiently activated by exposure of PC12 cells to UTP. UTP, ionomycin, and phorbol ester (phorbol 12-myristate 13-acetate) increased MAP kinase activity and also promoted the tyrosine phosphorylation of RAFTK, the epidermal growth factor (EGF) receptor, SHC, and p120(cbl). Down-regulation of PKC and inhibition of the elevation of [Ca2+]i, conditions that block the activation of MAP kinase, also blocked the increases in the tyrosine phosphorylation of RAFTK and the EGF receptor. AG1478, a tyrphostin selective for the EGF receptor, reduced the activation of MAP kinase, the tyrosine phosphorylation of SHC, the association of Grb2 with SHC, and the tyrosine phosphorylation of the EGF receptor and p120(cbl) but did not block the tyrosine phosphorylation of RAFTK. The similar effects of UTP, ionomycin, and phorbol 12-myristate 13-acetate (PMA) on these signaling proteins demonstrate that the two signaling molecules from phosphatidylinositol 4,5-bisphosphate hydrolysis ([Ca2+]i, from inositol 1,4,5-trisphosphate production, and diacylglycerol) can individually initiate the activation of MAP kinase in an EGF receptor-dependent manner. These results demonstrate that the P2Y2 receptor-mediated transactivation of the EGF receptor occurs at a point downstream of RAFTK and indicate that the EGF receptor is required for P2Y2 receptor-mediated MAP kinase activation. Although P2Y2 and EGF receptors may both activate a similar multiprotein signaling cascade immediately upstream of MAP kinase, the P2Y2 receptor appears to uniquely utilize [Ca2+]i, PKC, and, subsequently, RAFTK.

Citing Articles

Basal ATP release signals through the P2Y receptor to maintain the differentiated phenotype of vascular smooth muscle cells.

Chen X, Obukhov A, Weisman G, Seye C Atherosclerosis. 2024; 395:117613.

PMID: 38889566 PMC: 11254552. DOI: 10.1016/j.atherosclerosis.2024.117613.


ATP Promotes Oral Squamous Cell Carcinoma Cell Invasion and Migration by Activating the PI3K/AKT Pathway via the P2Y2-Src-EGFR Axis.

Zhou Q, Liu S, Kou Y, Yang P, Liu H, Hasegawa T ACS Omega. 2022; 7(44):39760-39771.

PMID: 36385800 PMC: 9648055. DOI: 10.1021/acsomega.2c03727.


Therapeutic potential for P2Y receptor antagonism.

Jasmer K, Munoz Forti K, Woods L, Cha S, Weisman G Purinergic Signal. 2022; 19(2):401-420.

PMID: 36219327 PMC: 10247620. DOI: 10.1007/s11302-022-09900-3.


Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines.

Reyna-Jeldes M, De la Fuente-Ortega E, Cerda D, Velazquez-Miranda E, Pinto K, Vazquez-Cuevas F Pharmaceutics. 2021; 13(8).

PMID: 34452195 PMC: 8398939. DOI: 10.3390/pharmaceutics13081234.


P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Woods L, Munoz Forti K, Shanbhag V, Camden J, Weisman G Biochem Pharmacol. 2021; 187:114406.

PMID: 33412103 PMC: 8096679. DOI: 10.1016/j.bcp.2021.114406.